MSITF (Medical Services International) Loans Receivable: $0.00 Mil (As of . 20)


What is Medical Services International Loans Receivable?

Medical Services International MSITF -99.00% Loans Receivable is $0.00 Mil as of . 20.

Medical Services International's Loans Receivable for the quarter that ended in . 20 was $0.00 Mil.

Medical Services International Loans Receivable Related Terms

Medical Services International Loans Receivable Historical Data

* Premium members only.

The historical data trend for Medical Services International's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Services International Loans Receivable Chart

Medical Services International Annual Data
Trend
Loans Receivable

Medical Services International Quarterly Data
Loans Receivable

Medical Services International Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
Medical Services International (MSITF) has a Loans Receivable of $0.00 Mil as of . 20. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Medical Services International and its competitors.
Is Medical Services International's Loans Receivable too high?
Medical Services International's current Loans Receivable is $0.00 Mil.
How does Medical Services International's Loans Receivable compare to FUTU and ADK?
Medical Services International's Loans Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Healthcare Providers & Services company?
A good Loans Receivable depends on the Healthcare Providers & Services industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Medical Services International and its competitors. Medical Services International's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Services International stock overvalued right now?
Medical Services International (MSITF) has a current Loans Receivable of $0.00 Mil. The current Loans Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Medical Services International (MSITF), the current Loans Receivable is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Services International Business Description

Address 5643 Riverbend Road, P.O. Box 59144, Edmonton, AB, CAN, T6H 5Y3
Medical Services International Inc provides medical diagnostic services and dialysis for Anguilla and surrounding islands. The company offers dialysis for travellers, manufactures, under contract, a home test kit for HIV and Hep C and contracts to perform clinical studies.